General Information of Drug (ID: DMZ8AL8)

Drug Name
BB3
Synonyms
3-(3,5-Dibromo-4-hydroxybenzoyl)-2-ethyl-N,N-dimethylbenzofuran-6-sulfonamide; 765317-71-3; 3-(3,5-DIBROMO-4-HYDROXY-BENZOYL)-2-ETHYL-BENZOFURAN-6-SULFONIC ACID DIMETHYLAMIDE; BB3; 3-(3,5-dibromo-4-hydroxybenzoyl)-2-ethyl-N,N-dimethyl-1-benzofuran-6-sulfonamide; SCHEMBL4320310; AC1L9M79; 1t48; ZINC14881085; AKOS025404898; DB04142; AK174884; N,N-Dimethyl-2-ethyl-3-(3,5-dibromo-4-hydroxybenzoyl)benzofuran-6-sulfonamide; 3-(3,5-dibromo-4-hydroxybenzoyl)-2-ethyl-N,N-dimethylbenzofuran -6-sulfonamide
Indication
Disease Entry ICD 11 Status REF
Cerebrovascular ischaemia 8B1Z Phase 3 [1]
Congestive heart failure BD10 Phase 3 [1]
Graft-versus-host disease 4B24 Phase 3 [2]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
Chemical Identifiers
Formula
C19H17Br2NO5S
Canonical SMILES
CCC1=C(C2=C(O1)C=C(C=C2)S(=O)(=O)N(C)C)C(=O)C3=CC(=C(C(=C3)Br)O)Br
InChI
1S/C19H17Br2NO5S/c1-4-15-17(18(23)10-7-13(20)19(24)14(21)8-10)12-6-5-11(9-16(12)27-15)28(25,26)22(2)3/h5-9,24H,4H2,1-3H3
InChIKey
FEYGJZKVMASWJB-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
448660
TTD ID
D0MY7F
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

References

1 Clinical pipeline report, company report or official report of Angion Therapeutics.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)